Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference
April 02 2024 - 6:59AM
Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating
genetic medicines for people living with rare and prevalent
diseases, announced that Geoff McDonough, M.D., president and chief
executive officer, will participate in a fireside chat at the 23rd
Annual Needham Virtual Healthcare Conference on Tuesday, April 9,
2024 at 12:45 p.m. ET.
A live webcast of the presentation will be available on the
investor section of the company’s website at
investors.generationbio.com. A replay will be available there for
30 days following the event.
About Generation Bio
Generation Bio is innovating non-viral genetic medicines to
provide durable and redosable treatments for hundreds of millions
of patients living with rare and prevalent diseases. The company is
developing two distinct and complementary platforms: a potent,
highly selective cell-targeted lipid nanoparticle (ctLNP) delivery
system and a novel immune-quiet DNA (iqDNA) cargo produced by a
scalable capsid-free manufacturing process that uses proprietary
cell-free rapid enzymatic synthesis (RES). With these platforms,
Generation Bio aims to develop the next wave of non-viral genetic
medicines to support its mission to extend the reach of genetic
medicine to more people living with more diseases, around the
world.
For more information, please visit www.generationbio.com.
Investors and Media ContactMaren
KillackeyGeneration Biomkillackey@generationbio.com857-371-4638
Generation Bio (NASDAQ:GBIO)
Historical Stock Chart
From Jul 2024 to Aug 2024
Generation Bio (NASDAQ:GBIO)
Historical Stock Chart
From Aug 2023 to Aug 2024